You are currently not taking any of our courses.
Educate both your staff and your customers with our different courses!
8.5 mm base curve/14.5 mm diameter
Power Ranges:
Sphere:
-6.50D to -9.00D (in 0.50D steps)
Plano to -6.00D (in 0.25D steps)
+0.25D to +4.00D (in 0.25D steps)
Cylinders:
-0.75D, -1.25D, -1.75D, -2.25D*
Axes:
10°-180° in 10° steps for Plano to -6.00D
70°-110° and 160°,170°,180°, 10°, 20° for -6.50D to -9.00D and +0.25D to +4.00D
* cylinder -2.25D available in power range Plano to -6.00D and axes 10°, 20°, 70°, 80°, 90°, 100°, 110°, 160°, 170°, 180°
Single usage: 1-day replacement
EYELID STABILISED Design is based on a four-zone stability system that utilises positive eyelid interaction by harnessing the power of the eye blink1
Packing solution contains boric acid and disodium tetraborate (sodium borate) to control the pH of the solution.
◊ Oxygen is only one of several factors related to maintaining overall eye health when wearing contact lenses.
^ Same coverage as ACUVUE® OASYS 1-DAY for ASTIGMATISM and ACUVUE® VITA for ASTIGMATISM.
# Based on in-vitro data, clinical studies have not been done directly linking differences in lysozyme profile with specific clinical benefits.
**All ACUVUE® contact lenses have Class 1 or Class 2 UV-blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. UV transmission measured with – 1.00D lens.
† 14 clinical studies posted on ClinicalTrials.gov, a website maintained by the NIH, evaluated subjective comfort as a primary or secondary endpoint for 1-DAY ACUVUE® MOIST brand family (spherical, astigmatism, and multifocal) contact lenses vs. competitors’ products. Published trials include comparisons between etafilcon A and nelfilcon A, omafilcon A, hilafilcon B, ocufilcon D and nesofilcon A. Review conducted as of April 30, 2024.
$ Based on publicly available manufacturer information as of March 2020.
1. JJV Data on file 2024, ACUVUE® Brand Contact Lenses for ASTIGMATISM overall fitting success, orientation position, rotational stability and vision performance.
2. JJV Data on File 2020. 1-DAY ACUVUE® MOIST Family Parameters Coverage
3. COVERAGE CLAIMS: JJV Data on file October 2023. Proportion astigmats accommodated with ACUVUE® Brand CLs for ASTIGMATISM
4. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
5. JJV Data on File 2018. Dual Action Technology and "Cushion of Moisture" Description for 1-DAY ACUVUE® MOIST Brand Family of Contact Lenses
6. Heynen M, Omali NB, Fadli Z, et al. Selectivity and localization of lysozyme uptake in contemporary hydrogel contact lens materials. J Biomater. Sci. Polym. Ed. 2017;28(13):1351-1364. doi: 10.1080/09205063.2017.1327751
7. JJV Data on File 2020. ACUVUE® Brand - EYE-INSPIRED™ Innovations.
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on Johnson & Johnson website www.e-IFU.com.
2024PP15399
Lens material | etafilcon A |
Technology |
LACREON® Technology EYELID STABILISED Design |
Dk/t (boundary & edge corrected)◊ |
23.8 x 10-9 |
Water content | 58% |
UV blocker4** | Class 2 |
Centre thickness at -3.00D (mm) | 0.09 |
Inside-out mark | No |
Visibility tint | Yes |
Package size | 30 or 90 lenses |
Packing solution contains boric acid and disodium tetraborate (sodium borate) to control the pH of the solution.
◊ Oxygen is only one of several factors related to maintaining overall eye health when wearing contact lenses.
^ Same coverage as ACUVUE® OASYS 1-DAY for ASTIGMATISM and ACUVUE® VITA for ASTIGMATISM.
**All ACUVUE® contact lenses have Class 1 or Class 2 UV-blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. UV transmission measured with – 1.00D lens.
† 14 clinical studies posted on ClinicalTrials.gov, a website maintained by the NIH, evaluated subjective comfort as a primary or secondary endpoint for 1-DAY ACUVUE® MOIST brand family (spherical, astigmatism, and multifocal) contact lenses vs. competitors’ products. Published trials include comparisons between etafilcon A and nelfilcon A, omafilcon A, hilafilcon B, ocufilcon D and nesofilcon A. Review conducted as of April 30, 2024.
$ Based on publicly available manufacturer information as of March 2020.
1. JJV Data on file 2024, ACUVUE® Brand Contact Lenses for ASTIGMATISM overall fitting success, orientation position, rotational stability and vision performance.
2. JJV Data on File 2020. 1-DAY ACUVUE® MOIST Family Parameters Coverage
3. JJV Data on File October 2023. Proportion astigmats accommodated with ACUVUE® Brand CLs for ASTIGMATISM.
4. JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1- DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStableTM Technology Brand Contact Lenses.
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on Johnson & Johnson website www.e-IFU.com.
2024PP15399